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Abstract
Background: Prompt access to effective malaria treatment is central to the success of malaria control worldwide, but 
few fevers are treated with effective anti-malarials within 24 hours of symptoms onset. The last two decades saw an 
upsurge of initiatives to improve access to effective malaria treatment in many parts of sub-Saharan Africa. Evidence 
suggests that the poorest populations remain least likely to seek prompt and effective treatment, but the factors that 
prevent them from accessing interventions are not well understood. With plans under way to subsidize ACT heavily in 
Kenya and other parts of Africa, there is urgent need to identify policy actions to promote access among the poor. This 
paper explores access barriers to effective malaria treatment among the poorest population in four malaria endemic 
districts in Kenya.
Methods: The study was conducted in the poorest areas of four malaria endemic districts in Kenya. Multiple data 
collection methods were applied including: a cross-sectional survey (n = 708 households); 24 focus group discussions; 
semi-structured interviews with health workers (n = 34); and patient exit interviews (n = 359).
Results: Multiple factors related to affordability, acceptability and availability interact to influence access to prompt 
and effective treatment. Regarding affordability, about 40 percent of individuals who self-treated using shop-bought 
drugs and 42 percent who visited a formal health facility reported not having enough money to pay for treatment, and 
having to adopt coping strategies including borrowing money and getting treatment on credit in order to access care. 
Other factors influencing affordability were seasonality of illness and income sources, transport costs, and unofficial 
payments. Regarding acceptability, the major interrelated factors identified were provider patient relationship, patient 
expectations, beliefs on illness causation, perceived effectiveness of treatment, distrust in the quality of care and poor 
adherence to treatment regimes. Availability barriers identified were related to facility opening hours, organization of 
health care services, drug and staff shortages.
 Conclusions : Ensuring that all individuals suffering from malaria have prompt access to effective treatment remains a 
challenge for resource constrained health systems. Policy actions to address the multiple barriers of access should be 
designed around access dimensions, and should include broad interventions to revitalize the public health care 
system. Unless additional efforts are directed towards addressing access barriers among the poor and vulnerable, 
malaria will remain a major cause of morbidity and mortality in sub-Saharan Africa.
Background
Prompt access to effective malaria treatment is central to
the success of malaria control worldwide. The Roll Back
Malaria (RBM) partnership has set for 2010 a target of
ensuring that 80 percent of those suffering from malaria
have prompt access to, and are able to correctly use,
affordable and appropriate treatment within 24 hours of
symptoms onset [1]. Most African countries are far below
these targets, with only a minority of fevers being treated
promptly and effectively [2-5]. The 2008 World Malaria
Report states that between 2006 and 2007, only 38 per-
cent of fevers reported among children under five were
treated with anti-malarials, and only three percent were
treated with artermisinin-based combination therapy
(ACT) [6], the official first-line anti-malarial for uncom-
plicated malaria in over forty African countries [7]. The
number of fevers treated promptly and effectively prior to
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the policy change from monotherapies to ACT was
equally low [8].
Low levels of ACT uptake can be attributed to various
factors including limited availability outside the public
sector, high costs, poor prescribing practices, and fre-
quent stock outs in public health care facilities [9-11].
Various initiatives to increase access to ACT have been
implemented or are in the process of implementation.
The Affordable Medicines Facility-malaria (AMFm) aims
to enable countries to increase the provision of affordable
ACT in the public, private and non-governmental organi-
zations through co-payment at factory gate [9]. Subsidies
will be accompanied by interventions such as shop-
keeper training programmes so as to increase availability
and safe use of ACT in the retail sector. A pilot study of
this delivery approach in Tanzania reported a dramatic
increase in access to ACT [10]. Community based inter-
ventions including the distribution of drugs by commu-
nity health workers have been equally successful [12-15].
Interventions targeting retailers implemented in the pre-
ACT era were effective in improving home management
of fevers [9,16-19], and looked cost-effective [20].
In Kenya, the malaria treatment policy was changed
from sulphadoxine/pyrimethamine (SP) to ACT arte-
mether-lumefantrine (AL) in 2006 [21]. Despite the pol-
icy change, amodiaquine remains the main anti-malarial
used to self-treat fever, and is widely prescribed by health
workers [22-24], even when ACT is available in health
care facilities [4,25]. The various types of ACT are 10 to
15 times more expensive than other anti-malarials [26,27]
and their availability is currently restricted to the public
and formal private health sector. Plans are however
underway to provide subsidized ACT in the private retail
sector through the AMFm subsidy [28]. While these are
potentially good developments for malaria control in
Kenya and elsewhere, existing evidence shows that the
poor benefit less from malaria control interventions than
higher income groups [29], and are less likely to seek
prompt effective treatment when they fall sick [30,31].
Given that reaching low income groups is essential for
equity and for the success of public health interventions,
it is important that the factors preventing low income
groups from accessing interventions and effective treat-
ment are better understood. This paper describes access
barriers to effective malaria treatment among the poorest
population in four malaria endemic districts in Kenya.
The WHO guidelines on malaria treatment recommend
that cases of suspected malaria are treated with a full
effective treatment irrespective of a confirmatory diag-
nostic test [27]. In this paper, prompt effective treatment
is defined as ability to correctly use appropriate anti-
malarials to treat suspected or confirmed malaria within
24 hours of symptoms onset.
What does access to malaria treatment entail?
There is no consensus on what access to health care
means and how it should be measured. Existing defini-
tions present access as a multifaceted concept, influenced
by multiple interrelated factors occurring at both the sup-
ply and demand level [32-37]. Recently, Thiede et al [37]
have developed an access framework that explores three
dimensions of access namely: (1) affordability, which
entails the full cost of health care vis-à-vis the ability to
pay for the services; (2) acceptability, which refers to the
compatibility between lay and professional health beliefs,
including patient perceptions of effectiveness of treat-
ment, and the extent to which their constructions of
health and healing match health workers' understanding
of these issues; and (3) availability, which goes beyond
physical location of health services to include opening
hours, ability and willingness of providers to serve the
population as well as type, range, quality and quantity of
services. Factors occurring at the different dimensions
interact to influence access to health care services.
Most studies that explore access to malaria treatment
focus on a single determinant of access primarily distance
to health care facilities, availability of anti-malarials, or
utilization of health care services. However, access to
malaria treatment is far broader than these indicators,
with a range of demand and supply side barriers poten-
tially hindering people from seeking prompt effective
malaria treatment. In addition to financial and physical
access barriers, examples of factors influencing access
include perceptions of illness causation, perceived and
actual effectiveness of treatment and quality of care, pro-
vider attitudes, adherence to drug dosage, power dynam-
ics within households, and availability of good quality
information. Understanding these barriers and how they
interact to influence treatment-seeking among the poor is
essential for improving effective case management. In
Kenya, the role of distance in access to malaria treatment
and morbidity levels is well documented [38-40], but
efforts to understand other barriers of access have been
relatively piecemeal. This paper draws on the framework
of Thiede et al [37] to consider the range of barriers to
prompt and effective malaria treatment among the poor-
est populations in Kenya.
Methods
The study was conducted in four districts in Kenya pur-
posively selected to represent different ecology and
malaria transmission patterns. Kwale district on the coast
with seasonal, high intensity transmission; Bondo district
on the shores of Lake Victoria with high intensity peren-
nial malaria transmission; Gucha district representing the
low seasonal transmission conditions of the Western
highlands; and Makueni, a semi arid district with acutely
seasonal, low transmission. There are also a wide range ofChuma et al. Malaria Journal 2010, 9:144
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research activities going on in the districts as part of
monitoring Kenya's progress to the Abuja targets [41-43].
According to the 1999 population census, the total pop-
ulation living in the districts are 952,752 people in Gucha,
952,000 in Kwale, 238,000 in Bondo and 771,545 people
in Makueni [44]. Gucha district is the most densely popu-
lated with a population density of 706 persons per square
kilometre, while Kwale is the least densely populated with
a population density of 60 persons per square kilometre.
The population density in Bondo and Makueni is 240 and
93.8 persons per square kilometre respectively. The pro-
portion of children aged below five years in the districts
ranges from 14% in Makueni to 17.3% in Kwale. The main
ethnic groups in Kwale and Bondo are the Mijikenda and
the Luo respectively. The Abagusii are the main ethnic
group in Gucha, while the Akamba are the main residents
of Makueni. Agriculture is the main source of income in
all districts. Additional information on the study districts
is provided elsewhere [45,46].
Data collection
The data presented in this paper come from a broader
study that aimed to explore barriers to effective treatment
and prevention among the poorest populations in Kenya.
Multiple data collection methods were applied in the
wider study to enhance reliability and validity. They
included a cross-sectional survey (n = 708 households),
focus group discussions (n = 24), semi-structured inter-
views with health workers in-charge of primary health
facilities in the districts (n = 34) and patient exit inter-
views (n = 361). The results presented in this paper are
mainly from the FGDS and patient exit interviews,
although data from the cross-sectional survey are pre-
sented where necessary to provided quantitative data on
key variables of interest.
The cross-sectional survey collected data on self-
reported fevers, treatment-seeking behaviour, treatment
barriers, costs and sources of money for treatment. Focus
Group Discussions (FGDs) explored barriers to access in
more detail, gathering in-depth information on the inter-
action between different factors and how they influence
access to prompt and effective treatment. Interviews with
health workers and patient exit interviews gathered pro-
viders and facility users' perspectives on various aspects
related to the access dimensions, including facility open-
ing hours, availability of drugs and provider-patient inter-
action.
Survey households were selected using multi-stage
sampling. A detailed description of the sampling
approach is published elsewhere [45,46], but briefly: First
locations-the 2nd  lowest administrative unit in Kenya-
were selected using poverty indicator maps generated by
the Kenya National Bureau of Statistics [47]. Second, four
enumeration areas (EAs) located in the two poorest quin-
t i l e s  i n  e a c h  d i s t r i c t  w e r e  r a n d o m l y  s e l e c t e d .  T h i r d ,  a
homestead list was updated and all homesteads in the
EAs were selected to take part in the study . Finally , all
households in the homestead were included in the study.
A two-week recall period was used to collect data on
self-reported fever (indicator for malaria) and treatment-
seeking patterns. FGDs participants were selected from
the same areas on the basis of age and gender. Priority
was given to men and women of reproductive age
because children are more vulnerable to malaria in the
study settings [48]. A few FGDs included older men and
women because of their important role in treatment-
seeking decisions [49,50]. Participants were drawn from
different parts of the village to maximize diversity. FGDs
were conducted up to the point of redundancy (n = 24).
All FGDs were tape recorded and notes taken for in-
depth interviews. Primary health care facilities were
selected purposively based on their proximity to the EAs,
and semi-structured interviews were held with all avail-
a b l e  h e a l t h  w o r k e r s .  P a t i e n t  e x i t  i n t e r v i e w s  w e r e  c o n -
ducted with all individuals who sought care from
participating health facilities on the date of the interview.
Data analysis
Quantitative data were double entered into Microsoft
visual FoxPro (version 9.0) and transferred to STATA
(version 9.2) for analysis. FGDs were transcribed and
analysed manually using content analysis. Data were first
analysed separately for each district and then brought
together to identify cross-cutting issues. The findings
were grouped together to give an indication of the overall
barriers that residents living in malaria endemic areas
face since key themes were generally similar across the
districts despite differences in malaria endemicity. To
ensure trustworthiness, two researchers independently
read and re-read the transcripts to identify codes, sub-
themes and themes.
Findings are organized around three broad access
dimensions common across various analytical frame-
works [32-37]. Within each dimension, there are a num-
ber of factors affecting both demand and supply side
determinants of access, although these factors do not
operate independently as demonstrated in Figure 1.
Quantitative data on each dimension are first presented
to provide a general overview of the determinants of
access at the community level, followed by qualitative
data which provide more detailed insights into the access
barriers, some of which are difficult to quantify.
Ethical approval
Ethical approval was obtained from the Kenya Medical
Research Institute (SSC No. 964), and the World Health
Organization Research Ethics Review Committee (ID
A50045).Chuma et al. Malaria Journal 2010, 9:144
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Results
Self-reported fever and treatment-seeking patterns among 
survey households
A summary of self-reported fevers and treatment-seek-
ing patterns is presented in Table 1. Fever was reported in
506 households (71.5%). A total of 1074 individuals
(25.5%) reported fever in the two weeks preceding the
survey. More fevers were reported among children under
five years of age than among older children and adults
(33.1% and 23.9% respectively). More than 90 percent of
reported fevers were treated; treatment levels were high
for both fevers reported under fives and the rest of the
population (91.5% and 90.6% respectively). Most fevers
were treated within the first two days of symptoms onset;
86.0% of fevers reported among children under five and
83.3% of fevers reported among the rest of the population
were treated within the first two days.
The informal sector was the main source of treatment
for all age groups. About 32% of fevers reported among
children under fives were treated using drugs bought
from the shops, 15.3% were treated using drugs bought
from chemists and 5.5% were treated using herbs. Among
adults, 37.7% of reported fevers were treated using drugs
from the shops, 17.0% using drugs from the chemist and
7.4% were treated using herbs. Only a minority of fevers
were treated at public and private health care facilities
(39.0%). The proportion of fevers treated in a public
health facility was 29.3% for illnesses reported among
children under five, and 19.2% for illnesses reported by
older children and adults. Private health facilities were
hardly used, with only 8.7% of all reported fevers treated
Figure 1 A summary of factors influencing access to prompt effective malaria treatment.
Affordability 
  Cost of treatment 
(official and non-
official) 
  Seasonality of illness 
and income 
  Drug shortages 
  Organisation of health 
care services 
  Transport costs 
 
Acceptability 
  Cost of treatment
  Illness perceptions 
  Effectiveness of treatment 
  Distrust in the health system 
  Provider patient interactions 
  Drug shortages 
   Drug adherence 
  Perceived low quality of care 
  Gender roles 
 
Broader health system factors including poor remuneration of health workers, high work load, staff 
shortage, distrust in the public health system 
Access to prompt effective malaria treatment 
Availability  
  Cost of treatment 
  Distance 
  Poor infrastructure  
  Drug shortages 
  Opening hours 
  Staff shortages 
  Provider attitudes 
  Poor work ethics 
  Organisation of health 
care services 
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at either a private or faith-based facility. Children aged
below five years were more likely to receive treatment at a
f o r m a l  h e a l t h  c a r e  f a c i l i t y  t h a n  o t h e r  a g e  g r o u p s  ( p  =
0.001).
Barriers to malaria treatment
Affordability related factors
Affordability is also commonly known as financial access
[33,34,37]. The cross-sectional survey identified lack of
money as a major barrier for seeking treatment: 61.5% of
individuals who did not seek treatment reported that
cash shortage was the main barrier (Table 1). Individuals
who treated fevers were asked if they had enough money
to pay for treatment. In 40.0% of all treatment actions
taken, money was not readily available at the time of
seeking treatment (Table 2). Lack of cash was common
among both individuals self-treating using drugs from the
shops (38.9%), and those that sought treatment in the for-
mal sector (41.8%). Where cash was not readily available
households adopted different coping strategies (Table 2).
Borrowing was the main source of cash for treatment
(25.4%). Money was mainly borrowed from friends and
neighbors (38.5%), and from relatives (36.9%). Other cop-
ing strategies included being treated on credit at a health
facility (17.6%), gifts (10.1%) and sale of assets (10.0%).
Sale of labor was hardly used as a source of money to pay
for treatment, but it was the main source of money for
paying debts that arose due to the treatment-seeking
(41.3%). Assets were also frequently sold in order to pay
for illness related debts (41.3%).
Qualitative data also identified affordability as a major
barrier to access. Affordability related barriers reported
in the FGDs included:
Table 1: Treatment-seeking patterns among survey households.
Variable Number (%) among children under five and the rest of the 
population
< 5 years > 5 years Total
Individuals reporting fever in the last 2 weeks 241 (33.1) 833 (23.9) 1074 (25.5)
Any action taken to treat fever
• Yes 246 (91.5) 776 (90.6) 1022 (90.8)
• No 23 (8.6) 81 (9.5) 104 (9.2)
Time taken before taking first treatment action
• < = 2days 191 (86.0) 636 (83.3) 827 (83.9)
• > = 3 days 31 (14.0) 124 (16.2) 155 (15.7)
• Don't know 4 (0.5) 0 (0) 4 (0.41)
Distribution of actions taken in response to illness
• Self treatment
 Drugs from shops 146 (31.9) 534 (35.9) 388 (37.7)
 Drugs from chemists 70 (15.3) 175 (17.0) 245 (16.5)
 Herbs 25 (5.5) 76 (7.4) 101 (6.8)
• Public health facility 134 (29.3) 197 (19.2) 331 (22.2)
• Private health facility 23 (5) 59 (5.8) 82 (5.5)
• Faith based facility 18 (3.9) 30 (2.9) 48 (3.2)
• Mobile clinic 26 (5.7) 78 (7.6) 104 (7.0)
• Other 15 (3.3) 28 (2.7) 43 (2.9)
Reasons for not seeking treatment
• Lack of money 13 (56.5) 51(63.0) 64 (61.5)
• Illness not serious 11 (47.8) 32 (39.5) 43 (41.3)
• Other 3 (13.0) 12 (14.8) 15 (14.4)Chuma et al. Malaria Journal 2010, 9:144
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Cost of treatment Costs of treatment as a barrier to
access was a predominant theme in all FGDs. High costs
reportedly prevented people from seeking effective treat-
ment despite knowing that malaria should be treated with
appropriate anti-malarials. Women experienced particu-
lar problems raising money for treatment. Alternative
cheap and ineffective sources of treatment were often
sought:
"There is this drug called coartem which is very expen-
sive [referring to the first-line anti-malarial in Kenya]. Its
price is about 900-1200 Kenya shillings (KES). When you
get a prescription to buy such a drug, given our economic
situation, one cannot afford to buy it, even when you are
seriously ill. That is why we have to resort to other means
like panadol [pain reliever] if only to get relief. We are even
more disadvantaged as women because our sources of
income are limited compared to men's." (FGD, Female)
"Sometimes parents do not have money to take their
children to a health facility. We buy medicines like pan-
adol [pain reliever] which we use to bring the fever down.
Then we believe that the child has recovered, but that is
not true...malaria continues to gain strength [meaning
becomes severe]." (FGD, Male)
Study participants reported that people who lacked
money to pay for treatment at the government facilities
were not given appropriate anti-malarials. This impacted
on people's perceptions of quality of care, acceptability of
services and contributed to poor drug adherence:
"We do not get proper treatment because money is
required at the dispensary.., but if you do not have the
money, you cannot be treated. If you have less money, then
y o u  w i l l  b e  g i v e n  d r u g s  t h a t  c a n n o t  c u r e  y o u . "  (FGD,
Female)
"If you do not have enough money, they [health workers]
give you a one-day dose and ask you to go with money the
next day to collect the remaining dose...But where is the
money? They give us an under-dose which is not good "
(FGD, Male)
Other affordability issues reported included cost of
transport and waiting time:
"You can find a household with four ill children. Giving
them treatment becomes difficult. First, transporting them
to the facility is a problem, raising money to pay for treat-
ment is difficult, and when you get to the dispensary, you
wait the whole day." (FGD, Male)
Seasonality of illness and income sources Seasonality
is an important factor influencing treatment-seeking for
malaria. In all FGDs, seasonality of malaria transmission
and income sources were identified as barriers to access.
FGD participants reported that malaria mainly occurs
during the peak agricultural season when people are busy
in the farms, and when most make a large proportion of
their annual cash income. Being ill during this period
therefore had significant impacts on people's income and
sometimes led to failure to treat illness in order to con-
tinue with income generating activities. Also, the queues
a t  t h e  h e a l t h  f a c i l i t i e s  w e r e  r e p o r t e d l y  l o n g e r  t h a n  i n
other times of the year, and drug supplies were felt to be
inadequa tely adjusted to meet the high demand in the
peak season:
"There are constant stock-outs during the rainy season
because there are many ill people. We suggest that the
quantity of drugs supplied during the rainy season be
increased to match the rising number of illnesses." (FGD,
Male)
"Getting proper treatment is usually a problem during
the wet season because many people fall sick. The dispen-
saries are also full during this period." (FGD, Male)
"Sometimes you are sick but you just have to continue
working because you have children looking upon you for
food. If you do not work, you will not harvest or get any
money to buy food for the children." (FGD, Female)
Table 2: Sources of money to pay for treatment.
Variable n = 1022 (%)
Had enough money to pay for treatment
• Yes 613 (60.0)
• No 409 (40.0)
Sources of money to pay for treatment
• Cash savings 636 (62.2*)
• Borrowing 260 (25.4)
• Gifts 103 (10.1)
• Casual labour 34 (3.3)
• Sale of assets 102 (10.0)
• Credit at health facility 180 (17.6)
• Waivers 12 (1.2)
• Other 26 (2.5)
Money borrowed/credit paid back at the 
time of survey?
• Yes 166 (37.7)
• No 274 (62.7)
Sources of cash to clear debts
• Cash 15 (9.0)
• Casual labour 69 (41.3)
• Sale of assets 69 (41.3)
• Gifts 12 (7.2)
• Other 12 (7.2)
*Total percentage > 100 because multiple strategies were 
sometimes adoptedChuma et al. Malaria Journal 2010, 9:144
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Incomes were also reported to be seasonal and unreli-
able, and most people struggled to make ends meet dur-
ing the difficult months of the year. During this period,
seeking effective treatment was beyond households' bud-
gets:
"The months from October to February are very dry and
most of us have nothing to do to raise money. You can look
after someone's goat for a day to get KES 20, but that is
nothing for anyone who has a family to feed, let alone take
a child to a health facility" (FGD, Male)
"There are particular months when it is difficult to get
money. During this time, there is no rainfall and therefore
no farming activities going on...there is no water for our
vegetable farms.., there is no money". (FGD, Female)
Informal or 'under-the-table' payments In addition to
formal charges, people occasionally reported giving
health workers some money to enable them receive 'good'
treatment quickly. These informal charges were some-
times high, increased the cost of treatment, and acted as
an access barrier:
"Some of them ask for tea [meaning under-the-counter
payment] of about KES 50 or KES 100 if one is to get good
drugs and faster treatment." (FGD, Male)
Acceptability related factors
Acceptability is sometimes referred to as cultural access
[32]. It involves the interactions between the health care
system and service users, provider and patient attitudes,
and expectations of each other [32,51]. It also includes
the compatibility between lay and professional health
beliefs, patients' perceptions of effectiveness of treat-
ment, and the extent to which their constructions of
health and healing match health workers' understanding
of these issues [32]. The cross-sectional survey collected
data on individuals' satisfaction with the quality of ser-
vices received at formal health care providers as an indi-
cator of acceptability. The results indicated that 311
individuals (55.0%) who sought treatment from formal
health care providers were satisfied with the services; 209
(36.9%) were dissatisfied and; 45 (8.0%) were indifferent.
The main reasons given for the dissatisfaction were the
quality of drugs received (23.2%) and lack of drugs
(23.2%); low confidence in staff ability to offer good qual-
ity treatment (17.8%), and lack of diagnostic tests (10.1%).
Satisfaction with services was linked primarily to avail-
ability and effectiveness of drugs, confidence in staff, and
short waiting time (69.1%, 13.1% and 3.6% respectively).
Qualitative data provided more insights on acceptabil-
ity related determinants of access:
Provider-patient interactions and perceptions on 
health workers' attitudes Provider and patient attri-
butes, expectations, beliefs and perceptions were identi-
fied as key factors influencing acceptability of formal
health care services. In Bondo district, older clients
reportedly found it difficult to accept treatment by youth-
ful providers, associating young health workers with
inadequate training and poor quality of care, including
disrespectful behaviour. In Gucha and Kwale districts
there were similar concerns about community health
workers (CHWs). Several comments suggested that these
concerns might be linked to broader problems of distrust
in health workers and dissatisfaction with the replace-
ment of older more familiar staff:
"It is their qualifications that we doubt.... The young
boys are not good but the older providers who worked here
before were good. We feel the drugs are there but they do
not know how to diagnose diseases and administer appro-
priate medication. They do not know how to hold the
syringe; they hold it like it is some pen for writing" (FGD,
Female).
"We have these people who are CHWs but they give
treatment at the health facility. When you go there, they
are the ones to inject you and when you get concerned and
ask him 'we have just come with you from home, are you
qualified to treat me?' He tells you to stay there untreated.
And when you go to the qualified doctors to complain, they
say that if you think the CHWs are not qualified, you
should bring your own doctor to the dispensary. At this
time you keep quiet and know that you are not going to get
proper treatment." (FGD, Female)
In many FGDs across the four districts, health workers
were reported to be inconsiderate and uncaring, and
these negative opinions apparently impacted on people's
willingness to seek care at public facilities. Although in
some cases health workers were said to lack commitment
and not to have the patients' interests at heart, others felt
the health workers were not solely to blame; that their
attitudes resulted from broader health system factors
associated with high work load and low remuneration:
"The other thing is the attitude of the health workers.
They do not care about the patients. It is like they do not
have a human heart or blood. They sit doing nothing all
day...we have to plead with them to attend to us." (FGD,
Male)
"It is because [referring to why quality of care is low] the
staff are few and the overwhelming number of patients
makes it impossible for them to give due attention to each
patient. They are also paid very low salaries yet they are
trained...they should be paid well." (FGD, Female)
"We cannot blame him [the provider] because he does
his best. Not even leaving for tea break or lunch...he treats
non-stop" (FGD, Male)
Perceptions of illness causes, effectiveness of 
treatment, and distrust in quality of care Malaria was
reported to be a common problem in all FGDs across the
four districts. The causes of malaria were not always
clear, with participants in about half the FGDs in all dis-
tricts attributing it to dirty water, coldness or weak blood.
High awareness of the need to treat malaria in formalChuma et al. Malaria Journal 2010, 9:144
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facilities was demonstrated in all FGDs. While people did
not always use anti-malarials to treat fevers, they attrib-
uted this to affordability and availability barriers rather
than lack of awareness of appropriate drugs. People
reported that they could easily diagnose malaria but that
their diagnoses sometimes conflicted with those of health
workers. Even when blood tests were reported as nega-
tive, patients reported that they sometimes bought
malaria drugs from shops or chemists anyway. In such
cases this may mean that additional, possibly unneces-
sary, costs are incurred by households:
"I was told that I did not have malaria, but when I went
to the chemist and bought malaria drugs for KES 80, I got
better. The following day I could attend to my duties with-
out much difficulty." (FGD, Male)
"Sometimes you feel that you are suffering from malaria
but when you visit the hospital, the tests show that there is
no malaria in your body. You are given panadol which
cannot cure you. If you have money, you will go to buy
malaria drugs." (FGD, Male)
Poor adherence to treatment Poor adherence to treat-
ment emerged as a barrier to effective treatment. Where
drugs were available and issued to patients at health facil-
ities, it was reported that people did not always adhere to
the dosage, either to save the medicine for future use, or
because drug administration timings were inconvenient,
especially for mothers who left their children behind to
go and work on the farms or to look for casual labor:
"Some parents do not follow the instructions they are
given by providers. Many parents fail to administer the
full dose to children as soon as they notice signs of recov-
ery. This happens mainly for the syrups...mothers want to
keep them for another day [meaning another illness epi-
sode]." (FGD, Male)
"It is the commitments that mothers have that make
them forget to give their children medicine. When the child
feels better, her mind switches to other things such as the
ever pressing need to cultivate vegetables by the lake. Once
she is by the lake she will not return home to give the child
medicine." (FGD, Female)
Unavailability of services and desperation were other
factors that contributed to poor adherence. People
r e p o r t e d  t h a t  p a t i e n t s  f a i l e d  t o  c o m p l e t e  t h e  d o s a g e ,
either because the medicine was not available at the facil-
ity, or the health workers did not open the dispensary due
to other commitments:
"Treatment can be effective, but for it to be effective one
has to comply. But when the health worker recommends,
for example three injections, the patient ends up receiving
one because the provider is either absent or the medicine is
not available." (FGD, Male)
"At times your neighbor might give you some drugs that
they are not using, and you take those drugs not knowing
what they treat or whether they are expired." (FGD,
Female)
Availability related factors
Availability (or physical access) refers to whether health
services and providers are supplied in the right place at
the right time, and whether the services offered corre-
spond with population's needs [32,33,35,37]. Key avail-
ability themes that emerged were facility opening hours,
drug shortages, and location and organization of health
services.
Facility opening hours One out of the 34 facilities cov-
ered was reported to operate 24 hours, seven days a week.
Most opened at 8.00 am every day (n = 28), and closed at
4.30 pm (n = 19). In 20 facilities, health workers reported
being contactable for emergency services out of hours
through mobile phones. In 10 facilities, the in-charge
reported having had to close the facility, either to attend a
workshop (n = 3), when summoned to the district head-
quarters by the district medical officer for health (n = 2),
or during annual leave (n = 3). These facilities were oper-
ated by only one health worker and, consequently, there
was no one to offer services in their absence.
The limited operating hours were repeatedly reported
as barriers to access in all districts, especially during the
weekends when primary health care facilities remained
closed:
"Sometimes the illness starts in the evening or during the
weekend when the dispensary is closed, so we are forced to
buy drugs from the shops. If it is a serious illness, you suffer
throughout the weekend or go to the district hospital if you
have the money, but this is rare. Few people have money to
go to the district hospital." (FGD, Male)
Closely related to official opening hours is that facilities
apparently often do not open on time. Community mem-
bers attributed this primarily to poor work ethics among
the health workers and inaccessible roads during the wet
season:
"The provider comes to the facility at his own time; he
opens late everyday and closes early. There is no consistent
time of opening or closing the facility and over the week-
ends there is no one to treat us." (FGD, Male)
"The provider leaves early because there is only one
vehicle plying this route and if he misses it, there are no
other means to town. During the rains, the roads are
impassable and at times the dispensary nurse-in-charge
cannot get here" (FGD, Female)
Others felt that health workers did the best they could
under the circumstances. Some facilities were under-
staffed, some had only one health worker, and in their
absence the health facilities remained closed or were
operated by community health workers.
"One problem is that we have only one health worker
who leaves on Friday early afternoon and reports back to
work on Monday afternoon. So from Friday through toChuma et al. Malaria Journal 2010, 9:144
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Monday we do not have anyone to treat us. Sometimes he
goes for a seminar the whole week and during this period
the dispensary remains closed" (FGD, Female)
Drug shortages Drug availability is another key factor
influencing access to treatment. Individuals who sought
treatment from public health facilities in the two weeks
preceding the survey were asked if they received all the
prescribed drugs from the hospital pharmacy and
whether or not they were issued with a prescription to
buy drugs from a private chemist. The results indicated
that 95 (30.0%) of people who visited public health facili-
ties did not get drugs from the hospital pharmacy and
were issued with a prescription to buy drugs elsewhere.
Of these, only 31 (32.8%) individuals bought the pre-
scribed drugs. Among exit interview participants, 140
(38.8%) did not receive drugs from the facility because
they were out of stock.
Persistent shortages of anti-malarials in public health
care facilities discouraged people from seeking effective
treatment. Participants in all FGDs were very vocal about
chronic drug shortages in the public health facilities and
the implications this had on affordability and treatment-
seeking behaviour:
"When you take your child to the health facility...first
you queue and pay for registration, then you are sent to
the first room where you pay for the rubber stamp, after
that you are told to go to the laboratory, where again they
tell you to pay for the tests, then you get to the pharmacy
and you are told there are no drugs. You go through this
long process and use all the money, but all you have are
receipts. What are you going to do with receipts? They
should have left you with your money to buy panadol or to
go to another health facility." (FGD, Female)
"The problem is that when you go to the hospital, the
health worker says there are no drugs, so all he does is to
write prescriptions or refer you to the district hospital. If
you have no money for drugs, where will you get money to
go to the district hospital? That is why malaria is killing
us...You will suffer until God decides to take the illness
away." (FGD, Male)
There were strong perceptions that health workers'
diverted public drugs to private chemists and clinics
where they often referred people to buy the prescribed
medicines. This behaviour, it was reported, was responsi-
ble for the chronic drug shortages in public health care
facilities:
"The health workers at the dispensary often ask patients
to go to their homes later in the evening or during the
weekend for treatment because there is no medicine at the
dispensary but they use drugs they have taken from the
dispensary." (FGD, Male)
"He opened a drug shop at the market and would steal
our drugs to sell to us at his shop until he was trans-
ferred..." (FGD, Female)
Shortage of anti-malarials in the health facilities was
also attributed to Coartem- the 1st line drug in Kenya-
being expensive and, therefore, the government could not
afford to restock the drug on time:
"The drugs at the dispensary are not good. We do not get
well after taking them. I think it is because the price of the
new drug [referring to ACT] is very high, and so it is never
in stock. The malaria drug that is sometimes in stock is
fansidar  [SP],  which no longer cures malaria." (FGD,
Male)
While many apparently blamed the health workers, a
few pointed out that it was difficult to confirm whether
the problem was in the supply of drugs from the govern-
ment or the behaviour of the health workers. Making
health facilities more accountable to the community was
identified as a potential mechanism for reducing and/or
confirming suspicions of drug theft:
"It is difficult to verify these claims. Nobody knows
whether the government brings drugs and no one checks
the pockets of the health workers to confirm that they steal
drugs." (FGD, Female)
"The community should have access to records showing
the amount of drugs received and how they have been dis-
pensed. This way, we can know if they [health workers]
steal drugs or not." (FGD, Male)
Location of health facilities Physical location of health
facilities in relation to service users and availability of
transport influence where, when and what sort of treat-
ment is sought. In almost all FGDs across the four dis-
tricts, participants reported that they had to travel for
long distances to a health facility. The poor road network
and limited sources of transport further compounded the
problem. Long distances also involved extra time and
financial costs:
"There is only one vehicle that passes here at 6 am and
a t  3  p m  t o  a n d  f r o m  t o w n  r e s p e c t i v e l y  a n d  w h e n  o n e
misses it, then one has to wait till the following day.... We
have nothing to do in case of an emergency" (FGD, Male)
"It is the distance from health facilities that makes it dif-
ficult for us to seek good quality treatment fast. It is not
easy to get a vehicle to the facilities and meet the costs of
transportation as well as for the treatment at the same
time. Sometimes we use bicycles but it is too far" (FGD,
Female)
Organization of health care services The way health
care facilities are structured may promote or hinder use
of health care services and thus act as a barrier to effec-
tive malaria treatment. Seeking treatment from public
health facilities was reportedly an unnecessarily long and
frustrating process, involving a number of stages. Patients
typically: pay the registration or card fees; take the card
for stamping and sometimes pay a stamping fee; see the
health worker who might recommend a parasitaemia test;
go to the laboratory and then return to the health workerChuma et al. Malaria Journal 2010, 9:144
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with the results; and finally go to the pharmacy to receive
available prescribed drugs. Each stage can involve signifi-
cant queuing and delays, making the system cumber-
some, with negative implications for patients trust in the
providers' and in the health system.
Discussion
This paper applies an access framework to explore access
barriers to effective malaria treatment among the poorest
populations in Kenya. Here, the results are discussed in
more detail and compared to the wider literature on
access to health care. Access to malaria treatment is
clearly influenced by multiple factors occurring at both
the supply and the demand level. A summary of the inter-
related barriers to access identified in this paper is pro-
vided in Figure 1.
Overall, a positive finding was that most reported
fevers were treated within the first 24 hours of symptoms
onset. Like in many parts of sub-Saharan Africa, over 50%
of reported fevers were treated using drugs bought in the
informal sector, with only about 20% treated in the public
sector, the main source of formal care in the study set-
tings. In Kenya, Coartem, the first-line anti-malarial, is
not sold in the informal sector, implying that a high pro-
portion of fevers treated in this sector were not treated
effectively. Moreover, evidence suggests that even fevers
treated in the formal public sector in the recent past have
hardly been treated using the recommended anti-malari-
als [3,4,24,52,53], due to various reasons related to all
access dimensions including drug shortages, patient's
preferences and perceived high costs of drugs [25]. Addi-
tional data on the types of medicines used to treat malaria
in the era of ACT, and the level of adherence to drug
regimes would be useful in measuring the country's prog-
ress towards the Abuja targets.
Demand-side factors
Affordability is a major barrier to malaria treatment and
health care throughout sub-Saharan Africa. On the
d e m a n d  s i d e ,  h e a l t h  c a r e  c h a r g e s ,  s e a s o n a l  i n c o m e s ,
transport costs and waiting time all interact to make
affordability a major barrier for the poorest households.
Ready cash to pay for treatment was hardly available and
households often mobilized additional resources mainly
through borrowing from their social networks. Lack of
money contributed to poor drug adherence since health
workers and drug shops were reported to readily issue
incomplete dosages. It was also reported that people who
lacked money to pay for treatment were given inappro-
priate drugs at government facilities because they were
reportedly cheaper than the recommended anti-malari-
als. Poor prescribing practices and drug adherence has
potential implications for drug resistance and acceptabil-
ity of services. For example, drug effectiveness was one of
the factors that patients attributed to the satisfaction or
otherwise of health services. Incomplete doses and less
effective drugs are likely to clear the symptoms in the
short-term, with the possibility of a recurring episode. As
shown by the findings, recurring illnesses that are treated
with incomplete doses or ineffective drugs can erode the
trust in the health system, and thus impacting negatively
on acceptability of health services.
All public health facilities in Kenya charge user fees. In
an attempt to make malaria treatment affordable, the
Kenyan government provides free anti-malarials to all
public health care facilities, which ideally should be dis-
pensed free of charge to malaria patients. Malaria treat-
m e n t  i s  t h e r e f o r e ,  o f f i c i a l l y  f r e e  t o  a l l  K e n y a n s .  I n  a
further development, in 2004, registration fees for
malaria patients in all primary health care facilities were
eliminated. However, the findings presented in this paper
and elsewhere suggest that health care charges remain a
significant barrier to access and that the 'free treatment'
policy is not fully implemented for various reasons
including [45]: (1) poor policy design, where patients are
required to pay consultation fees before being seen by a
health worker; (2) low revenue, especially in districts
where malaria is the main illness. Exempting malaria
patients from paying fees in malaria endemic districts
impacts heavily on the amount of revenue collected; (3)
the difficulties of identifying patients suffering from
malaria since many illness conditions have symptoms
similar to malaria and many primary health care facilities
do not have laboratories and; (4) shortage of drugs sup-
plied by the government meant that facilities had to raise
additional money through charging fees in order to raise
money to purchase drugs. The government should work
closely with health workers, district health management
teams and health facility committees to ensure that peo-
ple do not pay for anti-malarials in the public health sec-
tor. Non-health related interventions that address
insecurity and fragility of income sources can have a sig-
nificant role in minimizing affordability barriers and
improving effective treatment [54].
Regarding acceptability of treatment, about half of the
p e o p l e  t h a t  s o u g h t  c a r e  f r o m  f o r m a l  h e a l t h  s e r v i c e s
reported that they were satisfied with the quality of ser-
vices. Availability and effectiveness of drugs were the
main factors given for satisfaction with health services.
However, many community members in the study setting
appeared to have strong negative perceptions of health
workers attitudes and their ability to provide good quality
care. Health workers were often reported to be disre-
spectful to patients and their qualifications were some-
times questioned. Such perceptions may often relate to
cultural beliefs, which affect provider-patient interaction,
but also demonstrate the reluctance to accept new health
workers following transfer of more familiar and trustedChuma et al. Malaria Journal 2010, 9:144
http://www.malariajournal.com/content/9/1/144
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staff. The fact that the negative perceptions towards
health workers' age, gender and qualifications were
expressed mainly by elderly women implies that they may
have considerable cultural concerns, firstly, in exposing
their bodies for injection to providers who were predomi-
nantly young males, and secondly, in tolerating the lan-
guage of providers, which they regard as disrespectful to
their age and social status as married women. In districts
where CHWs assisted health workers to provide services
at the facility level, community members expressed con-
cerns regarding their expertise, and they were reluctant
to be attended by CHWs who were mainly from the same
community and well known to them. These findings
demonstrate the challenges of using CHWs to support
health workers in resource constraints regions. Plans are
under way in Kenya to roll out the community health
strategy that heavily relies on resources at the lower level,
including CHWs, to improve the health status of the pop-
ulation. The success of this strategy will to some extent
depend on the degree of CHWs acceptability at the com-
munity level.
Although the impact of negative perceptions of access
to effective malaria treatment is difficult to measure,
treatment-seeking behaviour has been shown to be
strongly influenced by social relationships. People draw
heavily on their social networks for advice; advice that is
shaped by perceptions and rumors about health workers,
quality of care and the health system in general [55-57].
Gilson notes that provider-patient relationships are influ-
enced by patients' attitudes towards providers [58]. For
example, providers personally known to patients or of the
same ethnic group or gender may be more trusted. How-
ever, providers may also introduce or reinforce negative
patient perceptions through their own practices [58].
Health system constraints, such as poor remuneration,
high workload and staff shortages, also play an important
role in influencing provider-patient relationships [51].
Although the role of provider patient relationships in
hindering or promoting access is well documented [59-
61], interventions to improve the situation are inade-
quately considered in policy design, particularly in low
income countries. In high and middle income countries,
mechanisms such as patients' rights charters exist to pro-
vide information to service users and improve on pro-
vider-patients relationships [62,63]. Similar initiatives
have been introduced in Kenya but the extent to which
the needs of the poor and vulnerable populations are met
has not been documented. Building trust in the public
health system through improving quality of care, making
providers more accountable to service users, and listen-
ing to community voices are essential to promoting
acceptability. Such interventions require long-term plan-
ning but a potential starting point should be a clear com-
mitment and willingness by policy makers to work
towards promoting and revitalizing the public health sys-
tem.
Supply side factors
On the supply side, the main barriers to access included
facility opening hours, distance to health care facilities,
poor road networks, drugs and staff shortages. About a
third of individuals who sought care from public health
facilities did not get drugs from the hospital pharmacy
because they were out of stock. Over half of the people
issued with prescriptions to buy medicines outside the
hospital pharmacy did not buy them.
People were particularly concerned about the chronic
drug shortages in public facilities, shortages that were
mainly attributed to inappropriate use by health workers.
Participants also reported that these shortages were more
serious during the wet season when the number of
malaria cases was high and health facilities could not
cope with the increased demand in malaria treatment.
Drug supplies were not adjusted to sustain the increased
demand. Lack of drugs can impact on acceptability of
health services. When people do not receive the appro-
priate drugs due to frequent stock out, they develop nega-
tive perceptions of health workers and have limited trust
in the health system. Drug shortages also contribute to
high costs of treatment, and thus impact on affordability.
Drug shortages in public health facilities mean that peo-
ple have to buy drugs from private chemists often at a
higher price, despite already having incurred some
charges - for example consultation and laboratory fees -
at the facility. It is worth considering the organization of
h e a l t h  c a r e  s e r v i c e s  t o  e n s u r e  t h a t  p e o p l e  o n l y  i n c u r
charges at the health services if drugs are available.
Shortage of first-line anti-malarials has been reported
as a main problem in the Kenyan health system
[11,24,45,53] and elsewhere in SSA [3,52]. A recent study
conducted in Kenya revealed that [11]: 26 percent of pub-
lic health facilities studied did not have any of the four AL
weight-specific packs in stocks and 75 percent had at
least one weight specific pack out of stock; a large pro-
portion did not have packs for the youngest ages (the
most vulnerable group to malaria); and some facilities
reported not having ACT for close to two months. It is
not clear why public health facilities experience chronic
drug shortages, but it is stipulated that the drug supply
system in Kenya is very inefficient. Other reasons include
seasonality of illness, failure to account for differences in
district health needs when designing the drug kits and
delayed supply [45]. The Kenyan government is aware of
the drug shortage problems in public health facilities and
plans are under way to change the drug supply system
from one where facilities receive standard drug kits, to a
pull system where facilities order their drugs based on
their need. The new approach has been piloted in someChuma et al. Malaria Journal 2010, 9:144
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parts of the country, although there is no information on
its effectiveness. It is important that the new drug supply
system is evaluated to ensure that it contributes to
improved drug supply in the public health care system.
Distance to health facilities and poor road networks
was not only a barrier to the community seeking care, but
they also influenced the presence of health workers at the
health facility. The public health facilities discussed in
this study are located in some of the remotest areas in the
districts with no housing facilities for the health workers.
Consequently, many of the health workers resided in
neighbouring towns and they often used public means of
transport on a daily basis, transport that was heavily
unreliable, and hardly operated during the rainy season
due to the poor road conditions. Few studies have docu-
mented the impact of physical infrastructure on health
workers ability to provide good quality services. While it
is difficult to confirm whether provider lateness was
mainly due to poor road network and unreliable trans-
port, the findings demonstrate the relationship between
availability and acceptability. Community members
attributed lateness of providers and few working hours to
poor work ethics and limited interest in their work and
rarely associated it with some of the constraints faced by
health workers.
Primary health care facilities were the main sources of
care in the study settings. These facilities only operated
within certain hours and remained closed during the
weekend. Beyond the official opening hours, there was no
source of formal care in these settings. Geographical
location of health care facilities has been reported as a
barrier to malaria treatment in Kenya [40,42,64], but few
studies identify primary health care facilities opening
hours as a barrier to effective treatment. The findings
have shown that primary health care facilities remain
closed during the weekends, and other periods when the
sole health worker is not available due to official or per-
sonal commitments. Yet these facilities are the closest to
the population and are the only formal sources of treat-
ment for the poorest population. Policy makers should
reconsider the operating hours of primary health care
facilities in remote rural settings. Other interventions
that can address the availability barriers include provid-
ing mobile clinics and outreach programmes. These
interventions will, however, require that additional health
workers are deployed to these facilities and that appropri-
Table 3: Policy actions to address barriers of access to prompt and effective malaria treatment.
Short to medium term interventions
Affordability factors Acceptability factors Availability factors Broader health system factors
• Provide ACTs through the retail 
sector
• Re-enforce the free malaria 
treatment policy in public health 
facilities
• Educate people on the free 
malaria treatment policy
• Improve communication skills 
for health workers
• Educate community on the 
importance of drug adherence
• Strengthen transparency and 
accountability of health services 
to the community (e.g. making 
information on resources readily 
accessible to the community 
through their representatives)
• Extend operating hours for 
dispensaries and health centres to 
include weekends
• Improve management skills for 
health workers and health facility 
committees
• Ensure sustained supply of anti-
malarials, adjust supply for 
seasonality
• Provide housing facilities for 
health workers working at 
primary care level in remote rural 
areas
• Recruit more health workers in 
primary care facilities
• Take services close to the people 
through mobile clinics and 
outreach programmes
• Improve overall availability of 
drugs and other supplies
Long term interventions
• Remove user fees in public 
health facilities
• Provide social protection for the 
poor and vulnerable through 
strengthening livelihoods
• Build culturally sensitive health 
systems (educate health workers 
on need to respect clients and be 
sensitive to their needs)
• Empower clients to demand 
good health services through 
information and communication 
at grass root level
• Build additional primary health 
care facilities in remote areas
• Increase the number of health 
workers in rural remote areas to at 
least two health workers per 
facility
• Address the problem of health 
workers shortage
• Improve organization and 
administration of service, for 
example through packaging 
services in way that minimizes 
waiting time
• Improve the organization and 
working culture of the public 
health systemChuma et al. Malaria Journal 2010, 9:144
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ate anti-malarials and other essential drugs are readily
available.
Table 3 summarizes the possible policy actions to
addresses barriers to effective malaria treatment identi-
fied in this paper. These actions involve the three access
dimensions and include both short-term and long-term
interventions. Interventions relating to the broader
health system are also identified.
Limitations
A limitation of this work is that the findings are based on
comments and reports of samples of people living in four
poor rural settings in Kenya. Although the aim was to
understand barriers to access among the poorest popula-
tion, the urban poor might face different barriers due to
contextual differences related to better infrastructure and
more health care facilities. Regarding formal treatment,
people discussed public health facilities far more than
private facilities. This is most likely because no private
providers operated in close proximity to these low
income settings. However , the fact that people did not
discuss about treatment in the private formal sector sug-
gests that this sector is beyond the reach of the poorest
population.
Conclusions
Ensuring that all individuals suffering from malaria have
prompt access to effective treatment is a major challenge
for resource constrained health systems. Policy actions to
address the multiple barriers of access should be designed
around all dimensions of access, and should also include
broad interventions to revitalize the public health care
system. Unless additional efforts are directed towards
addressing the barriers to access among the poor and vul-
nerable population, malaria will remain a major cause of
morbidity and mortality in SSA.
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